🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, randomized study to investigate the relative bioavai...
Status
Completed
Location
Quotient Clinical
Start Date
2017-02-27
Trial ID
NCT03202784
Treatments Being Tested
This is an open-label study to evaluate the long term safety and effectiven...
Status
Completed
Location
Study Center
Start Date
2018-02-16
Trial ID
NCT03472040
Treatments Being Tested
This is a 3-part Phase 1 dose-ranging study to evaluate the safety, tolerab...
Status
Completed
Location
Quotient Clinical
Start Date
2015-05
Trial ID
NCT02448264
Treatments Being Tested
This is a phase 3, multi-center, randomized, double-blind, placebo-controll...
Status
Completed
Location
Study Site
Start Date
2018-12-27
Trial ID
NCT03873116
Treatments Being Tested
This is an open-label, three part study to evaluate the effect of BCX7353 o...
Status
Completed
Location
Covance CRU
Start Date
2017-02-17
Trial ID
NCT03136237
Treatments Being Tested
This 3-part study will evaluate the efficacy and safety of an oral kallikre...
Status
Completed
Location
Study Center
Start Date
2017-07-31
Trial ID
NCT03240133
This is an open-label, single sequence study to evaluate the effect of BCX7...
Status
Completed
Location
Quotient Clinical Ltd
Start Date
2016-03
Trial ID
NCT02819102
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics (PK), safety ...
Status
Active Not Recruiting
Location
Investigative Site #1
Start Date
2022-10-25
Trial ID
NCT05453968
Treatments Being Tested
This 3-part study will evaluate the safety and efficacy of an oral treatmen...
Status
Completed
Location
Multiple Locations
Start Date
2016-08
Trial ID
NCT02870972
This is a phase 3, multicenter, randomized, double-blind, placebo-controlle...
Status
Completed
Location
Study center
Start Date
2018-02-06
Trial ID
NCT03485911
Treatments Being Tested